Kelly Paul Edward
SEC insider (Form 3/4/5 filer). CIK 0001658544. Director at RELMADA THERAPEUTICS, INC. (RLMD). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 12, 2025. Located in CORAL GABLES,, FL.
Companies Kelly Paul Edward has filed insider reports for
- RELMADA THERAPEUTICS, INC. (RLMD): Director
Kelly Paul Edward
CIK: 0001658544
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RELMADA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Dec 12, 2025RLMD
RELMADA THERAPEUTICS, INC.
AwardDirectStock Appreciation Rights
828K shares- - Nov 5, 2025RLMD
RELMADA THERAPEUTICS, INC.
PurchaseDirect90K shares at avg. $2.20$198K - Jun 26, 2025RLMD
RELMADA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
400K shares- - May 16, 2025RLMD
RELMADA THERAPEUTICS, INC.
PurchaseDirect200K shares at avg. $0.43$86K - Sep 9, 2024RLMD
RELMADA THERAPEUTICS, INC.
PurchaseDirect25K shares at avg. $2.59$65K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 12, 2025 | RLMD RELMADA THERAPEUTICS, INC. | Award Stock Appreciation Rights | 828,000 | - | - | Direct |
| Nov 5, 2025 | RLMD RELMADA THERAPEUTICS, INC. | Purchase | 90,000 | $2.20 | $198,000 | Direct |
| Jun 26, 2025 | RLMD RELMADA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 400,000 | - | - | Direct |
| May 16, 2025 | RLMD RELMADA THERAPEUTICS, INC. | Purchase | 200,000 | $0.43 | $86,060 | Direct |
| Sep 9, 2024 | RLMD RELMADA THERAPEUTICS, INC. | Purchase | 25,000 | $2.59 | $64,750 | Direct |
1-5 of 5 transactions